Significantly elevated concentration of plasma monocyte chemotactic protein 1 of patients with pelvic inflammatory disease

Reproductive Sciences

Volumn 17, Issue 6, 2010, Pages 549-555

  Hsiao, Pei Ching ^a,b   Wang, Po Hui ^a,b   Tee, Yi Torng ^a,b   Yang, Shun Fa ^a   Su, Pen Hua ^a,b   Chen, Yi Chen ^a   Lin, Long Yau ^a,b   Tsai, Hsiu Ting ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Monocyte chemotactic protein 1; Pelvic inflammatory disease; Single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN; CEFOTETAN; CEFOXITIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; PELVIC INFLAMMATORY DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77952373568     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110362593     Document Type: Article

References (29)

1. Latthe P., Latthe M., Say L., Gulmezoglu M., Khan KS WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006 ; 6: 177.
2. Martinez TM, Reid SI, Arias C., Napolitano RC, Sandoval ZJ, Molina CR Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan Region [in Spanish]. Rev Med Chil. 2008 ; 136 (10). 1294-1300.
3. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep. 2009 ; 58 (14). 362-365.
4. Takahashi M., Galligan C., Tessarollo L., Yoshimura T. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol. 2009 ; 183 (5). 3463-3471.
5. Chan RW, Lai FM, Li EK, et al. Intrarenal cytokine gene expression in lupus nephritis. Ann Rheum Dis. 2007 ; 66 (7). 886-892.
6. Booth G., Newham P., Barlow R., Raines S., Zheng B., Han S. Gene expression profiles at different stages of collagen-induced arthritis. Autoimmunity. 2008 ; 41 (7). 512-521.
7. Agic A., Xu H., Finas D., Banz C., Diedrich K., Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest. 2006 ; 62 (3). 139. 147.
8. Nakashima H., Fujimoto M., Asashima N., et al. Serum chemokine profile in patients with bullous pemphigoid. Br J Dermatol. 2007 ; 156 (3). 454-459.
9. Christodoulakos GE, Lambrinoudaki IV, Economou EV, et al. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis. 2007 ; 193 (1). 142-150.
10. Tucci M., Quatraro C., Frassanito MA, Silvestris F. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. J Hypertens. 2006 ; 24 (7). 1307-1318.
11. Iwai N., Kajimoto K., Kokubo Y., et al. Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J. 2006 ; 70 (7). 805-809.
12. Dayan L. Pelvic inflammatory disease. Aust Fam Physician. 2006 ; 35 (11). 858-862.
13. Bagavant H., Adams S., Terranova P., et al. Autoimmune ovarian inflammation triggered by proinflammatory (Th1) T cells is compatible with normal ovarian function in mice. Biol Reprod. 1999 ; 61 (3). 635-642.
14. Lee J., Zhao X. Recombinant human interleukin-8, but not human interleukin-1beta, induces bovine neutrophil migration in an in vitro co-culture system. Cell Biol Int. 2000 ; 24 (12). 889-895.
15. Rovin BH, Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999 ; 259 (2). 344-348.
16. Chakravarti A. To a future of genetic medicine. Nature. 2001 ; 409 (6822). 822-823.
17. DAddabbo A., Latiano A., Palmieri O., et al. Association of genetic profiles to Crohns disease by linear combinations of single nucleotide polymorphisms. Artif Intell Med. 2009 ; 46 (2). 131-138.
18. Workowski KA, Berman SM Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006 ; 55 (RR-11). 1-94.
19. Angerman NS, Evans MI, Moravec WD, Schumacher GF, Hajj SN C-reactive protein in the evaluation of antibiotic therapy for pelvic infection. J Reprod Med. 1980 ; 25 (2). 63-66.
20. Hadgu A., Westrom L., Brooks CA, Reynolds GH, Thompson SE Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol. 1986 ; 155 (5). 954-960.
21. Gu L., Tseng S., Horner RM, Tam C., Loda M., Rollins BJ Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000 ; 404 (6776). 407-411.
22. Inoue S., Egashira K., Ni W., et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2002 ; 106 (21). 2700-2706.
23. Schepers A., Eefting D., Bonta PI, et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2006 ; 26 (9). 2063-2069.
24. Akoum A., Lemay A., McColl S., Turcot-Lemay L., Maheux R. Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril. 1996 ; 66 (1). 17-23.
25. Szalai C., Duba J., Prohaszka Z., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients Atherosclerosis. 2001 ; 158 (1). 233-239.
26. Gonzalez-Escribano MF, Torres B., Aguilar F., et al. MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum Immunol. 2003 ; 64 (7). 741-744.
27. Cermakova Z., Petrkova J., Arakelyan A., et al. The MCP-1- 2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet. 2005 ; 32 (5). 315-318.
28. Dechkum N., Hananantachai H., Patarapotikul J., et al. Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand. Jpn J Infect Dis. 2006 ; 59 (4). 239-244.
29. Park BL, Kim YJ, Cheong HS, et al. Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp Mol Med. 2006 ; 38 (6). 694-702.